CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totaling 7,816 shares, a drop of 75.9% from the July 15th total of 32,429 shares. Based on an average daily volume of 78,247 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s stock are sold short.
CochLear Price Performance
CHEOY stock traded up $0.43 during trading on Thursday, hitting $46.91. 3,524 shares of the company’s stock were exchanged, compared to its average volume of 57,634. The business has a 50-day moving average price of $40.92 and a two-hundred day moving average price of $52.68. CochLear has a 52-week low of $31.82 and a 52-week high of $104.65.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada downgraded shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price on the stock. in a research note on Thursday, July 16th. UBS Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Finally, Jefferies Financial Group cut CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $117.00.
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than CochLear
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
- Axos Financial Keeps Proving the Digital Banking Model Works
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
